{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:12:06Z","timestamp":1791857526420,"version":"4.3.4"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"vor","delay-in-days":1461,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/ki.2013.254","type":"journal-article","created":{"date-parts":[[2013,6,26]],"date-time":"2013-06-26T12:39:12Z","timestamp":1372250352000},"page":"886-894","source":"Crossref","is-referenced-by-count":52,"title":["Recent advances in the noninvasive diagnosis of renal osteodystrophy"],"prefix":"10.1016","volume":"84","author":[{"given":"Ranjani N.","family":"Moorthi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon M.","family":"Moe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2013.254_bb0010","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0140-6736(02)37965-0","article-title":"On a form of late rickets associated with albuminuria","volume":"1","author":"Lucas","year":"1883","journal-title":"Lancet"},{"key":"10.1038\/ki.2013.254_bb0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1126\/science.95.2467.388","article-title":"Treatment of renal osteodystrophy with dihydrotachysterol (A.T.10) and iron","volume":"95","author":"Liu","year":"1942","journal-title":"Science"},{"key":"10.1038\/ki.2013.254_bb0020","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S8756-3282(01)00642-1","article-title":"Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression","volume":"30","author":"Parfitt","year":"2002","journal-title":"Bone"},{"key":"10.1038\/ki.2013.254_bb0030","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1046\/j.1525-139x.2000.00042.x","article-title":"The role of the bone biopsy in the diagnosis of renal osteodystrophy","volume":"13","author":"Sprague","year":"2000","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2013.254_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5414\/CNP65235","article-title":"Renal osteodystrophy: what\u2019s in a name? Presentation of a clinically useful new model to interpret bone histologic findings","volume":"65","author":"Malluche","year":"2006","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2013.254_bb0040","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1038\/sj.ki.5000311","article-title":"Osteoporosis in hemodialysis patients revisited by bone histomorphometry: a new insight into an old problem","volume":"69","author":"Barreto","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0045","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/j.ajkd.2007.08.019","article-title":"Increased risk of hip fracture among men with CKD","volume":"51","author":"Dooley","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.254_bb0055","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","article-title":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocoritcoid-Induced Osteoporosis","volume":"44","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1038\/ki.2013.254_bb0060","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/ki.1993.64","article-title":"The spectrum of bone disease in end-stage renal failure\u2013an evolving disorder","volume":"43","author":"Sherrard","year":"1993","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0065","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1440-1797.2009.01148.x","article-title":"Review article: Bone biopsy in chronic kidney disease: patient level end-point or just another test?","volume":"14","author":"Jorgetti","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/ki.2013.254_bb0070","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00223-010-9367-y","article-title":"The bone histology spectrum in experimental renal failure: adverse effects of phosphate and parathyroid hormone disturbances","volume":"87","author":"Batista","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"Suppl 3","key":"10.1038\/ki.2013.254_bb0075","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/ndt\/11.supp3.111","article-title":"Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients","volume":"11","author":"Monier-Faugere","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.254_bb0080","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","article-title":"A structural approach to renal bone disease","volume":"13","author":"Parfitt","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.254_bb0085","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1359\/jbmr.2002.17.10.1741","article-title":"Parathyroid hormone and periosteal bone expansion","volume":"17","author":"Parfitt","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.254_bb0090","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.semnephrol.2009.01.006","article-title":"A structural approach to skeletal fragility in chronic kidney disease","volume":"29","author":"Leonard","year":"2009","journal-title":"Semin Nephrol"},{"key":"10.1038\/ki.2013.254_bb0095","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jocd.2010.06.002","article-title":"In vivo precision of the GE Lunar iDXA densitometer for the measurement of total-body, lumbar spine, and femoral bone mineral density in adults","volume":"13","author":"Hind","year":"2010","journal-title":"J Clin Densitom"},{"key":"10.1038\/ki.2013.254_bb0100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s001980050224","article-title":"Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis","volume":"10","author":"Genant","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2013.254_bb0105","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1172\/JCI113523","article-title":"Age and bone mass as predictors of fracture in a prospective study","volume":"81","author":"Hui","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2013.254_bb0110","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1359\/jbmr.2001.16.12.2163","article-title":"Reconsidering the effects of antiresorptive therapies in reducing osteoporotic fracture","volume":"16","author":"Chesnut","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.254_bb0115","first-page":"S1","article-title":"Clinical Practice Guidelines for the Management of CKD-MBD","volume":"76","author":"KDIGO","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0120","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.254_bb0125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2013.254_bb0130","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1172\/JCI59327","article-title":"MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death","volume":"122","author":"Aurora","year":"2012","journal-title":"JClin Invest"},{"key":"10.1038\/ki.2013.254_bb0135","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1053\/j.ajkd.2007.02.264","article-title":"Low bone mineral density and fractures in long-term hemodialysis patients: a meta-analysis","volume":"49","author":"Jamal","year":"2007","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.254_bb0140","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11255-010-9723-x","article-title":"Vitamin D insufficiency and bone fractures in patients on maintenance hemodialysis","volume":"43","author":"Ambrus","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1038\/ki.2013.254_bb0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0150","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000184007","article-title":"Comparison of histomorphometry and computerized tomography of the spine in quantitating trabecular bone in renal osteodystrophy","volume":"44","author":"Torres","year":"1986","journal-title":"Nephron"},{"key":"10.1038\/ki.2013.254_bb0155","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00774-008-0030-x","article-title":"Determinants of prevalent vertebral fractures and progressive bone loss in long-term hemodialysis patients","volume":"27","author":"Mares","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1038\/ki.2013.254_bb0160","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1359\/jbmr.060105","article-title":"Cortical pQCT measures are associated with fractures in dialysis patients","volume":"21","author":"Jamal","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.254_bb0165","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.2215\/CJN.09711010","article-title":"Bone microarchitecture in hemodialysis patients assessed by HR-pQCT","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1525-139X.2012.01096.x","article-title":"Determination of bone architecture and strength in men and women with stage 5 chronic kidney disease","volume":"25","author":"West","year":"2012","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2013.254_bb0175","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1681\/ASN.2009121208","article-title":"Bone mass and microarchitecture in CKD patients with fracture","volume":"21","author":"Nickolas","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0180","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1007\/s00198-012-1908-y","article-title":"Bone mineral density by DXA and HR pQCT can discriminate fracture status in men and women with stages 3 to 5 chronic kidney disease","volume":"23","author":"Jamal","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2013.254_bb0185","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9290(95)80008-5","article-title":"A new method to determine trabecular bone elastic properties and loading using micromechanical finite-element models","volume":"28","author":"van Rietbergen","year":"1995","journal-title":"J Biomech"},{"key":"10.1038\/ki.2013.254_bb0190","first-page":"1221","article-title":"Alterations of bone microstructure and strength in end-stage renal failure","volume":"24","author":"Trombetti","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2013.254_bb0195","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s001980200003","article-title":"Changes in calcaneal trabecular bone structure assessed with high-resolution MR imaging in patients with kidney transplantation","volume":"13","author":"Link","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2013.254_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jmri.20085","article-title":"Quantitative high-resolution magnetic resonance imaging reveals structural implications of renal osteodystrophy on trabecular and cortical bone","volume":"20","author":"Wehrli","year":"2004","journal-title":"J Magn Reson Imaging"},{"key":"10.1038\/ki.2013.254_bb0205","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00198-012-2103-x","article-title":"Skeletal effects of zoledronic acid in an animal model of chronic kidney disease","volume":"24","author":"Allen","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1038\/ki.2013.254_bb0210","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bone.2012.07.029","article-title":"Raman spectroscopy demonstrates Amifostine induced preservation of bone mineralization patterns in the irradiated murine mandible","volume":"52","author":"Tchanque-Fossuo","year":"2012","journal-title":"Bone"},{"key":"10.1038\/ki.2013.254_bb0215","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1007\/s11999-010-1692-y","article-title":"Raman assessment of bone quality","volume":"469","author":"Morris","year":"2011","journal-title":"Clin Orthop Relat Res"},{"key":"10.1038\/ki.2013.254_bb0220","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bone.2011.11.008","article-title":"Applications of atomic force microscopy for the assessment of nanoscale morphological and mechanical properties of bone","volume":"50","author":"Wallace","year":"2012","journal-title":"Bone"},{"key":"10.1038\/ki.2013.254_bb0225","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1359\/jbmr.2000.15.1.2","article-title":"The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption","volume":"15","author":"Hofbauer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1038\/ki.2013.254_bb0230","series-title":"Predictive value of biomarkers for bone turnover in ESKD Abstract presentation, Renal Week 2010","author":"B-fE Malluche","year":"2010"},{"key":"10.1038\/ki.2013.254_bb0235","series-title":"Dietary References Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride","author":"Institute of Medicine","year":"1997"},{"key":"10.1038\/ki.2013.254_bb0240","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1440-1797.2009.01131.x","article-title":"Review article: Chronic kidney disease-mineral bone disorder: have we got the assays right?","volume":"14","author":"Zidehsarai","year":"2009","journal-title":"Nephrology (Carlton)"},{"key":"10.1038\/ki.2013.254_bb0245","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/MNH.0b013e3283470450","article-title":"Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question","volume":"20","author":"Moorthi","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/ki.2013.254_bb0250","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.clinbiochem.2012.03.023","article-title":"Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum","volume":"45","author":"Koivula","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1038\/ki.2013.254_bb0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s00774-003-0476-9","article-title":"Effect of hemodialysis and renal failure on serum biochemical markers of bone turnover","volume":"22","author":"Alvarez","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"10.1038\/ki.2013.254_bb0260","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.cca.2006.08.021","article-title":"Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b","volume":"376","author":"Ohashi","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1038\/ki.2013.254_bb0265","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2265.2008.03187.x","article-title":"Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunction","volume":"69","author":"Yamada","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1038\/ki.2013.254_bb0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.bone.2003.04.002","article-title":"Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption","volume":"34","author":"Hannon","year":"2004","journal-title":"Bone"},{"key":"10.1038\/ki.2013.254_bb0275","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","author":"Nickolas","year":"2011","journal-title":"J AmSoc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0280","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00467-009-1384-6","article-title":"FGF-23 in bone biology","volume":"25","author":"Wesseling-Perry","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1038\/ki.2013.254_bb0285","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1210\/jc.2008-0326","article-title":"Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis","volume":"94","author":"Wesseling-Perry","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/ki.2013.254_bb0290","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"key":"10.1038\/ki.2013.254_bb0295","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2013.254_bb0300","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1093\/emboj\/cdg599","article-title":"Osteocyte control of bone formation via sclerostin, a novel BMP antagonist","volume":"22","author":"Winkler","year":"2003","journal-title":"EMBO J"},{"key":"10.1038\/ki.2013.254_bb0305","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2215\/CJN.07670712","article-title":"The relation between renal function and serum sclerostin in adult patients with CKD","volume":"8","author":"Pelletier","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0310","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2215\/CJN.06550810","article-title":"Sclerostin and Dickkopf-1 in renal osteodystrophy","volume":"6","author":"Cejka","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0315","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ndt\/gfr270","article-title":"Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients","volume":"27","author":"Cejka","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.254_bb0320","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2215\/CJN.09471209","article-title":"Variability of parathyroid hormone and other markers of bone mineral metabolism in patients receiving hemodialysis","volume":"5","author":"Gardham","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0325","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1523-1755.2005.00513.x","article-title":"Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry","volume":"68","author":"Lehmann","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0330","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.ajkd.2009.12.041","article-title":"Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study","volume":"55","author":"Herberth","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.254_bb0335","first-page":"S1","article-title":"KDIGO: clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2013.254_bb0340","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1046\/j.1523-1755.2003.00129.x","article-title":"Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease","volume":"64","author":"Sawaya","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0345","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1053\/j.ajkd.2005.09.024","article-title":"PTH and the risks for hip, vertebral, and pelvic fractures among patients on dialysis","volume":"47","author":"Danese","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.254_bb0350","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1053\/ajkd.2000.19812","article-title":"Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone","volume":"36","author":"Coco","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2013.254_bb0355","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0360","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1681\/ASN.2007010022","article-title":"Fracture risk after parathyroidectomy among chronic hemodialysis patients","volume":"18","author":"Rudser","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0365","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.2012.77","article-title":"Bone-specific alkaline phosphatase concentrations are less variable than those of parathyroid hormone in stable hemodialysis patients","volume":"82","author":"Sardiwal","year":"2012","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2013.254_bb0370","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2013.254_bb0375","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/ndt\/13.9.2294","article-title":"Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients","volume":"13","author":"Coen","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/ki.2013.254_bb0380","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/ki.2008.248","article-title":"High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death","volume":"74","author":"Blayney","year":"2008","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815560742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T12:37:57Z","timestamp":1645879077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815560742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0085253815560742"],"URL":"https:\/\/doi.org\/10.1038\/ki.2013.254","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}